# We've Used GLP-1s for 3 Years: What Worked, What Backfired, and What Women Need to Know

Page: https://stenobird.com/podcast/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468/we-ve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know
Text version: https://stenobird.com/podcast/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468/we-ve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know.md
Podcast: [The Hormone Solution | Menopause, Perimenopause, & Women's Midlife Health](https://stenobird.com/podcast/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468)
Published: 2026-04-25T12:00:00+00:00
Episode link: https://karenmartel.libsyn.com/weve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know
Audio file: https://mgln.ai/e/35/pscrb.fm/rss/p/traffic.libsyn.com/secure/karenmartel/Hormone_Solution_Podcast_-_Weve_Used_GLP-1s_for_3_Years_What_Worked_What_Backfired_and_What_Women_Need_to_Know_NO_AD_VERSION.mp3?dest-id=815799
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468/episodes/we-ve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know
Duration seconds: 4289

## Resource

Three years ago, GLP-1 peptides were barely being talked about in the midlife women's health space. Since then, Jessica and I have personally used them, experimented with different approaches, and helped over a thousand women inside our peptide program navigate what works, what backfires, and what women in perimenopause and menopause need to know before jumping in. In this episode, we're pulling back the curtain on our own GLP-1 journeys, including my rough start with Ozempic, why Tirzepatide worked better for me, Jessica's experience with Semaglutide and fatigue, and why Retatrutide is becoming one of the most talked-about peptides right now. We also get into one of the biggest myths floating around online: that GLP-1s automatically cause massive muscle loss. The truth is much more nuanced. We talk about the biggest mistakes we see women making. How Glp1s can impact insulin sensitivity, inflammation, fat cell biology, blood sugar regulation, liver metabolism, and even brain reward pathways. We also dive into some of the peptides we're loving right now beyond GLP-1s, including NAD, KPV, MOTS-c, and Tesamorelin, and why peptide therapy can be powerful when it's used intelligently, not recklessly. This is a real, honest conversation about how to use these tools in a way that supports long-term health, metabolism, muscle, and hormones, instead of chasing fast weight loss at any cost. In this episode, we cover: Our personal three-year journey using GLP-1 peptides Why Ozempic, Semaglutide, Tirzepatide, and Retatrutide can feel very different The truth about GLP-1s and muscle loss Why appetite suppression is not the only sign a GLP-1 is working The biggest mistakes women make with dosing and titration Why protein, amino acids, digestion, and strength training matter so much…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468/episodes/we-ve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-hormone-solution-menopause-perimenopause-women-s-midlife-health-440468/we-ve-used-glp-1s-for-3-years-what-worked-what-backfired-and-what-women-need-to-know.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.